Zobrazeno 1 - 10
of 1 218
pro vyhledávání: '"Clausen V"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Hersey S; Bristol-Myers Squibb, Lawrenceville, NJ, USA., Keller S; AbbVie, South San Francisco, CA, USA., Mathews J; Ionis, Carlsbad, CA, USA., King L; Pfizer, Cambridge, MA, USA., Bandukwala A; US FDA, Silver Spring, MD, USA., Berisha F; Janssen R&D, Spring House, PA, USA., Birchler M; GlaxoSmithKline, Collegeville, PA, USA., Bower J; Precision for Medicine, Bethesda, MD, USA., Clausen V; Alnylam, Cambridge, MA, USA., Duarte J; F. Hoffmann-La Roche, Basel, Switzerland., Garofolo F; BRI - a Frontage Company, Vancouver, BC, Canada., Hopper S; UK MHRA, London, UK., Kar S; WRIB, Montreal, QC, Canada., Mabrouk O; Biogen, Cambridge, MA, USA., Marshall JC; Moderna, Cambridge, MA, USA., McGuire K; Regeneron, Tarrytown, NY, USA., Naughton M; GlaxoSmithKline, Stevenage, UK., Saito Y; Japan MHLW-NIHS, Tokyo, Japan., Schuhmann I; Novartis, Basel, Switzerland., Sperinde G; Genentech, South San Francisco, CA, USA., Teixeira P; F. Hoffmann-La Roche, Basel, Switzerland., Vitaliti A; Novartis, Basel, Switzerland., Wang YM; US FDA, Silver Spring, MD, USA., Wnek R; Merck, Kenilworth, NJ, USA., Zhang Y; Bristol-Myers Squibb, Lawrenceville, NJ, USA., Spitz S; Incyte Research Institute, Wilmington, DE, USA., Decman V; GlaxoSmithKline, Philadelphia, PA, USA., Eck S; AstraZeneca, Gaithersburg, MD, USA., Estevam J; Takeda, Cambridge, MA, USA., Goihberg P; Pfizer, Andover, MA, USA., Alcaide EG; F. Hoffmann-La Roche, Basel, Switzerland., Gonneau C; Labcorp, Meyrin, Switzerland., Hedrick MN; Bristol-Myers Squibb, Lawrenceville, NJ, USA., Hopkins G; Bluebird Bio, Cambridge, MA, USA., Junker F; F. Hoffmann-La Roche, Basel, Switzerland., Nuti S; GSK vaccines, Rockville, MD, USA., Sommer U; Novartis, Basel, Switzerland., Standifer N; AstraZeneca, South San Francisco, CA, USA., Stevens C; Pfizer, Cambridge, MA, USA., Stevens E; Pfizer, Groton, CT, USA., Hendricks C; Sanofi, Framingham, MA, USA., Wadhwa M; UK MHRA, London, UK., Torri A; Regeneron, Tarrytown, NY, USA., Ma M; Alexion, New Haven, CT, USA., Harris S; HilleVax, Cambridge, MA, USA., Kumar S; EMD Serono, Andover, MA, USA., Partridge MA; Regeneron, Tarrytown, NY, USA., Caiazzo T; Pfizer, Cambridge, MA, USA., Chilewski S; Bristol-Myers Squibb, Lawrenceville, NJ, USA., Cludts I; UK MHRA, London, UK., Coble K; Boehringer Ingelheim, Ridgefield, CT, USA., Gorovits B; Sana Bio, Cambridge, MA, USA., Grimaldi C; Boehringer Ingelheim, Ridgefield, CT, USA., Jordan G; Roche Pharma Research & Early Development, Roche Innovation Center, Munich, Germany., Kamerud J; Pfizer, Cambridge, MA, USA., Leary B; Pfizer, Cambridge, MA, USA., Liang M; AstraZeneca, South San Francisco, CA, USA., Lim H; Genentech, South San Francisco, CA, USA., Mayer A; GlaxoSmithKline, Collegeville, PA, USA., O'Connor E; AstraZeneca, Gaithersburg, MD, USA., Palackal N; Regeneron, Tarrytown, NY, USA., Poetzl J; Sandoz, Munich, Germany., Prior S; UK MHRA, London, UK., Abhari MR; US FDA, Silver Spring, MD, USA., Savoie N; WRIB, Montreal, QC, Canada., Soo C; Health Canada, Ottawa, ON, Canada., Ware M; Janssen R&D, Spring House, PA, USA., Wu B; Janssen R&D, Spring House, PA, USA., Xu Y; Merck, West Point, PA, USA., Yang TY; Janssen R&D, Spring House, PA, USA., Zoghbi J; Sanofi, Framingham, MA, USA.
Publikováno v:
Bioanalysis [Bioanalysis] 2022 May; Vol. 14 (10), pp. 627-692. Date of Electronic Publication: 2022 May 17.
Autor:
Li J; Alnylam Pharmaceuticals Inc., Cambridge, Massachusetts., Liu J; Alnylam Pharmaceuticals Inc., Cambridge, Massachusetts., Zhang X; Alnylam Pharmaceuticals Inc., Cambridge, Massachusetts., Clausen V; Alnylam Pharmaceuticals Inc., Cambridge, Massachusetts., Tran C; Alnylam Pharmaceuticals Inc., Cambridge, Massachusetts., Arciprete M; Alnylam Pharmaceuticals Inc., Cambridge, Massachusetts., Wang Q; Alnylam Pharmaceuticals Inc., Cambridge, Massachusetts., Rocca C; Alnylam Pharmaceuticals Inc., Cambridge, Massachusetts., Guan LH; Alnylam Pharmaceuticals Inc., Cambridge, Massachusetts., Zhang G; Alnylam Pharmaceuticals Inc., Cambridge, Massachusetts., Najarian D; Alnylam Pharmaceuticals Inc., Cambridge, Massachusetts., Xu Y; Alnylam Pharmaceuticals Inc., Cambridge, Massachusetts., Smith P; Alnylam Pharmaceuticals Inc., Cambridge, Massachusetts., Wu JT; Alnylam Pharmaceuticals Inc., Cambridge, Massachusetts., Chong S; Alnylam Pharmaceuticals Inc., Cambridge, Massachusetts schong@alnylam.com.
Publikováno v:
Drug metabolism and disposition: the biological fate of chemicals [Drug Metab Dispos] 2021 Jul; Vol. 49 (7), pp. 572-580. Date of Electronic Publication: 2021 May 03.
Autor:
Castolo-Sanchez, Samir1,2 (AUTHOR) gmanases@hotmail.com, Zamilpa, Alejandro2 (AUTHOR) azamilpa_2000@yahoo.com.mx, Herrera-Ruiz, Maribel2 (AUTHOR), Trejo-Espino, José Luis1 (AUTHOR) jtrejo@ipn.mx, Domínguez-Mendoza, Blanca Eda3 (AUTHOR) bed@uaem.mx, González-Cortazar, Manasés2 (AUTHOR), Trejo-Tapia, Gabriela1 (AUTHOR) azamilpa_2000@yahoo.com.mx
Publikováno v:
Pharmaceuticals (14248247). Nov2024, Vol. 17 Issue 11, p1534. 18p.
Autor:
Cicala, Giuseppe1 (AUTHOR) gcicala@unime.it, Rottura, Michelangelo1 (AUTHOR) cristiano.federica977@gmail.com, Gianguzzo, Viviana Maria2 (AUTHOR) vivianamaria.gianguzzo@unime.it, Cristiano, Federica1 (AUTHOR) sedrago@unime.it, Drago, Selene Francesca Anna1 (AUTHOR) nirrera@unime.it, Pallio, Giovanni3 (AUTHOR) gpallio@unime.it, Irrera, Natasha1 (AUTHOR) eimbalzano@unime.it, Imbalzano, Egidio1 (AUTHOR) espina@unime.it, Spina, Edoardo1 (AUTHOR) varcoraci@unime.it, Arcoraci, Vincenzo1 (AUTHOR)
Publikováno v:
Pharmaceuticals (14248247). Oct2024, Vol. 17 Issue 10, p1365. 15p.
Autor:
Roodbergen, Kees Jan, Kolman, Inger B., Zijm, W.H.M., Klumpp, M., Clausen, V., Ten Hompel, M.
Publikováno v:
Logistics and Supply Chain Innovation ISBN: 9783319222875
Logistics and Supply Chain Innovation: Bridging the Gap between Theory and Practice, 183-196
STARTPAGE=183;ENDPAGE=196;TITLE=Logistics and Supply Chain Innovation
Logistics and Supply Chain Innovation: Bridging the Gap between Theory and Practice, 183-196
STARTPAGE=183;ENDPAGE=196;TITLE=Logistics and Supply Chain Innovation
This paper addresses the challenge of making multichannel decisions for order fulfillment and logistics. We present a framework for multichannel strategies consisting of seven elements. Some channel decisions are part of the marketing mix, with the u
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bd74c9284ba2809150221ed87a32185a
https://doi.org/10.1007/978-3-319-22288-2_11
https://doi.org/10.1007/978-3-319-22288-2_11
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Aplin, Cody1,2 (AUTHOR), Zielinski, Kara A.3 (AUTHOR), Pabit, Suzette3 (AUTHOR), Ogunribido, Deborah1 (AUTHOR), Katt, William P.2 (AUTHOR), Pollack, Lois3 (AUTHOR), Cerione, Richard A.1,2 (AUTHOR) rac1@cornell.edu, Milano, Shawn K.1,2 (AUTHOR)
Publikováno v:
Communications Biology. 8/13/2024, Vol. 7 Issue 1, p1-16. 16p.
Autor:
Sun, Huiyan1 (AUTHOR), Wang, Xinxia1 (AUTHOR), Li, Yongqiang2 (AUTHOR), Shen, Yingzhi1 (AUTHOR), Zhang, Lin1 (AUTHOR), Xu, Yingjie1 (AUTHOR), Liu, Junling1,2 (AUTHOR) liujl@shsmu.edu.cn, Fan, Xuemei1 (AUTHOR) liujl@shsmu.edu.cn
Publikováno v:
Pharmaceutics. Jul2024, Vol. 16 Issue 7, p938. 20p.
Autor:
Fandozzi C; Merck, West Point, PA, USA., Evans C; GlaxoSmithKline, Collegeville, PA, USA., Wilson A; Clinical Pharmacology & Safety Sciences, Translational Biomarker & Bioanalysis, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK., Su D; Genentech, South San Francisco, CA, USA., Anderson M; Merck, Philadelphia, PA, USA., Clausen V; Alnylam Pharmaceuticals, Cambridge, MA, USA., Dillen L; Janssen Research & Development, Beerse, Belgium., Garofolo F; Angelini Pharma, Pomezia, RM, Italy., Holliman C; Pfizer, Groton, CT, USA., Nickbarg E; Merck, Boston, MA, USA., Olah T; Bristol-Myers Squibb, Princeton, NJ, USA., Ramanathan R; Pfizer, Groton, CT, USA., Zhang H; Pfizer, Groton, CT, USA., Kaur S; Genentech, South San Francisco, CA, USA., Pillutla R; Bristol-Myers Squibb, Princeton, NJ, USA., Yu H; Boehringer-Ingelheim, Ridgefield, CT, USA., Bateman K; Merck, West Point, PA, USA., Donato LD; Caprion, Montreal, QC, Canada., Hengel S; Seattle Genetics, Inc., Bothell, WA, USA., Jian W; Janssen Research & Development, Spring House, PA, USA., Jones B; Q2 Solutions, Ithaca, NY, USA., Kellie J; GlaxoSmithKline, Collegeville, PA, USA., Lee A; Merck, Kenilworth, NJ, USA., Palandra J; Pfizer, Andover, MA, USA., Savoie N; CFABS, Montreal, QC, CAN., Shipkova P; Bristol-Myers Squibb, Princeton, NJ, USA., Spitz S; Incyte, Wilmington, DE, USA., Su D; Genentech, South San Francisco, CA, USA., Szapacs M; GlaxoSmithKline, Collegeville, PA, USA., Wang J; Bristol-Myers Squibb, Princeton, NJ, USA., Wright K; Pfizer, Andover, MA, USA., Zeng J; Bristol-Myers Squibb, Princeton, NJ, USA.
Publikováno v:
Bioanalysis [Bioanalysis] 2019 Nov; Vol. 11 (22), pp. 2029-2048. Date of Electronic Publication: 2019 Dec 06.